Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400081159Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of Zishen Yutai Pill in Endometrial hypotrophy (2 arms), sponsored by Renji Hospital. Primary endpoint: Ongoing pregnancy rate. Planned start Feb 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400081159.